[Frailty and surgical tolerability in elderly patients undergoing robot-assisted radical cystectomy (RARC)].

Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
PMID:

Abstract

Robot-assisted radical cystectomy (RARC) has become a gold standard therapeutic option for muscle-invasive bladder cancer and selected cases with T1 bladder cancer. Due to the rapid aging worldwide and the outstanding performance of the da Vinci surgical system, the surgical indication of RARC in elderly men is often a matter of controversy. In this manuscript, we investigated previous literature regarding the complication rates and frailty among elderly patients undergoing RARC for bladder cancer.

Authors

  • Yuta Yamada
    Department of Urology, Graduate School of Medicine, The University of Tokyo, Hongo7-3-1, Bunkyo-ku, Tokyo, Japan.
  • Haruki Kume
    Department of Urology, Graduate School of Medicine, The University of Tokyo, Hongo7-3-1, Bunkyo-ku, Tokyo, Japan.